GlassScriptPhysician profile
Eric M Jeffries
NPI 1790757045
$19,175.79
in general payments reported to CMS, 2019-2025
68 companies · $2,950 in 2025
The $2,950 reported for 2025 was more than what 79% of Neurology (Psychiatry & Neurology) providers received nationally (typical 2025 total: $454).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,815 · 2020: $1,556 · 2021: $2,447 · 2022: $3,333 · 2023: $3,798 · 2024: $3,277 · 2025: $2,950.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $10K · Education: $3.40.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $10,021.05 |
| Education | $3.40 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $2,601.82 | 2021-2025 | |
| Novartis Pharmaceuticals Corporation | $2,429.63 | 2019-2025 | |
| Pfizer INC. | $1,532.59 | 2021-2025 | |
| Teva Pharmaceuticals USA, INC. | $1,376.58 | 2019-2025 | Austedo Xr, Austedo, Austedo Xr |
| Biogen, INC. | $1,040.29 | 2019-2025 | Vumerity, Tysabri, Skyclarys |
| Lilly USA, LLC | $907.34 | 2019-2025 | Amyvid, Emgality, Kisunla |
| Ucb, INC. | $613.24 | 2019-2024 | Rystiggo |
| Amgen INC. | $530.20 | 2019-2025 | Uplizna |
| Lundbeck LLC | $507.23 | 2020-2025 | Vyepti, Rexulti |
| Acadia Pharmaceuticals INC | $456.75 | 2019-2025 | Nuplazid |
| Emd Serono, INC. | $439.30 | 2019-2024 | |
| Alexion Pharmaceuticals, INC. | $421.21 | 2019-2025 | Soliris, Ultomiris |
| Amneal Pharmaceuticals LLC | $388.84 | 2019-2025 | Ongentys, Crexont, Rytary |
| Sunovion Pharmaceuticals INC. | $385.00 | 2019-2022 | |
| Genentech USA, INC. | $357.64 | 2019-2025 | Ocrevus, Ocrevus Zunovo |
Show all 68 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Biohaven Pharmaceutical Holding Company LTD. | $342.20 | 2022 | |
| Genzyme Corporation | $281.55 | 2019-2025 | |
| Neurocrine Biosciences, INC. | $276.47 | 2020-2025 | Ingrezza, Ongentys |
| Banner Life Sciences, LLC | $237.31 | 2021-2024 | |
| Kyowa Kirin, INC. | $237.25 | 2022-2025 | Nourianz |
| Allergan, INC. | $230.90 | 2019-2022 | |
| Celgene Corporation | $229.74 | 2021-2023 | Zeposia |
| Eisai INC. | $222.10 | 2022-2025 | |
| Axsome Therapeutics, INC. | $215.97 | 2023-2025 | Sunosi, Symbravo |
| Argenx US, INC. | $214.34 | 2022-2025 | Vyvgart, Vyvgart Hytrulo |
| Mdd US Operations, LLC | $207.36 | 2019-2025 | Gocovri, Gocovri |
| Neurelis, INC. | $198.73 | 2021-2023 | Valtoco |
| Mallinckrodt Hospital Products INC. | $186.61 | 2021-2025 | Acthar |
| Biohaven Pharmaceuticals, INC. | $178.45 | 2021 | |
| Upsher-Smith Laboratories LLC | $164.72 | 2019-2023 | |
| Csl Behring | $158.56 | 2020-2024 | Hizentra |
| Tg Therapeutics, INC. | $158.49 | 2023-2025 | |
| Livanova USA, INC. | $135.64 | 2019-2023 | Vns Therapy Sentiva Model 1000 Generator |
| Adamas Pharmaceuticals, INC. | $97.38 | 2019-2021 | |
| Janssen Pharmaceuticals, INC | $80.19 | 2021-2022 | |
| Jazz Pharmaceuticals INC. | $79.54 | 2020-2023 | Epidiolex |
| Grifols USA, LLC | $69.11 | 2023-2024 | Gamunex-C |
| Avion Pharmaceuticals | $69.08 | 2022-2023 | Dhivy |
| Impel Pharmaceuticals INC. | $64.08 | 2023 | Trudhesa |
| Acorda Therapeutics, INC | $61.89 | 2019-2021 | |
| E.R. Squibb & Sons, L.L.C. | $59.78 | 2020-2021 | |
| Supernus Pharmaceuticals, INC. | $59.72 | 2019-2021 | |
| Sk Life Science, INC. | $42.27 | 2022-2023 | |
| Horizon Therapeutics Plc | $42.05 | 2020-2022 | |
| Abbott Laboratories | $39.46 | 2019-2023 | Infinity |
| Catalyst Pharmaceuticals, INC. | $38.68 | 2023-2024 | Fycompa |
| Cycle Pharmaceuticals INC | $34.39 | 2024-2025 | Bafiertam, Ormalvi |
| Alnylam Pharmaceuticals INC. | $32.98 | 2025 | Amvuttra |
| Arbor Pharmaceuticals, INC. | $32.92 | 2019-2022 | |
| Sumitomo Pharma America, INC. | $30.43 | 2023 | Aptiom |
| Almatica Pharma LLC | $29.25 | 2021 | |
| Nevro Corp. | $27.71 | 2022 | |
| Vanda Pharmaceuticals INC. | $27.47 | 2024 | Ponvory |
| Corium, LLC | $27.09 | 2023 | Adlarity |
| Globus Medical, INC. | $26.66 | 2025 | Senza |
| Xeris Pharmaceuticals, INC. | $23.40 | 2025 | Keveyis |
| Merz Pharmaceuticals, LLC | $22.29 | 2023 | Xeomin |
| Otsuka America Pharmaceutical, INC. | $21.84 | 2025 | Rexulti |
| Averitas Pharma INC. | $21.45 | 2024 | Qutenza |
| Assertio Therapeutics, INC. | $19.12 | 2019 | |
| Scilex Pharmaceuticals INC. | $18.75 | 2023 | Ztlido |
| Astrazeneca Pharmaceuticals LP | $18.24 | 2025 | Wainua |
| Insightec,INC | $17.45 | 2023 | Exablate |
| Vertical Pharmaceuticals, LLC | $17.20 | 2019 | |
| Octapharma USA, INC. | $16.53 | 2023 | Panzyga |
| Tonix Medicines, INC. | $16.24 | 2025 | Tonmya |
| Merck Sharp & Dohme LLC | $14.38 | 2021 | |
| Avanir Pharmaceuticals, INC. | $12.72 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Eric Jeffries listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.